Koers Callitas Health Inc. Canadian Securities Exchange
Aandelen
LILY
CA13125C1068
Biotechnologie & Medisch Onderzoek
Omzet 2018 | 0,75 1,02 0,69 | Omzet 2019 | 0,71 0,97 0,65 | Marktkapitalisatie | 3,53 mln. 4,81 mln. 3,24 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2018 | -5 mln. -6,81 mln. -4,6 mln. | Nettowinst (verlies) 2019 | -1 mln. -1,36 mln. -920K | EV/omzet 2018 | 4.852.616 x |
Nettoschuld 2018 | 319K 435K 294K | Nettoschuld 2019 | 848K 1,16 mln. 780K | EV/omzet 2019 | 6.168.166 x |
K/w-verhouding 2018 |
-0,6
x | K/w-verhouding 2019 |
-1,97
x | Werknemers | - |
Dividendrendement 2018 * |
-
| Dividendrendement 2019 |
-
| Vrij verhandelbaar | 72,04% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | - | 03-01-18 | |
Robert Payment
DFI | Director of Finance/CFO | 42 | - |
Brian Keane
BRD | Director/Board Member | 47 | - |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Donald Skeith
BRD | Director/Board Member | 69 | 01-12-14 |
William Rodgers
BRD | Director/Board Member | - | - |
Brian Keane
BRD | Director/Board Member | 47 | - |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+41,79% | 54,04 mld. | |
-0,56% | 41,92 mld. | |
+47,64% | 41,96 mld. | |
-7,20% | 28,35 mld. | |
+12,59% | 26,35 mld. | |
-21,51% | 19 mld. | |
+6,92% | 13 mld. | |
+24,91% | 12,19 mld. | |
+29,60% | 12,28 mld. |